# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zelda Fitzgerald (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET004-SYN-TD
- Date: 1930-06-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margot Ellery, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Lithium level after the sick visit, prolactin, and the antipsychotic plan. **S**

## History of present illness

Ms. Fitzgerald returns one week after the sick visit for gastroenteritis, when her lithium level was 1.4 mmol/L. She held lithium for two days as advised, was eating and drinking normally by the third day, and restarted 300 mg twice daily five days ago. The diarrhea stopped within four days. Her tremor is back to a faint shake when she is tired. She admits that she did not go for the lithium level that was due a week after starting, because she felt well and forgot. Her mood is better, and she has had no manic or psychotic symptoms. She saw the sports dietitian and is eating three meals and two snacks; she has started one gentle class a day. Her periods have not returned. She has had no thoughts of suicide or self-harm. **S**

| Element | Detail |
|---|---|
| Lithium | Held two days, restarted five days ago at 300 mg twice daily |
| Gastroenteritis | Resolved |
| Mood | Better; PHQ-9 7; item 9 scored 0 |
| Periods | Still absent |
| Food and dance | Three meals and two snacks; one gentle class a day |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | Diarrhea and vomiting resolved; eating normally |
| Genitourinary | Positive | No periods; no increased urination |
| Neurological | Negative | Faint tremor only when tired; no unsteadiness or confusion |
| Psychiatric | Negative | Mood better; no manic or psychotic symptoms; no thoughts of suicide or self-harm |

4 systems reviewed. **S**

## Current medications

- Lithium carbonate 300 mg oral capsule, one capsule by mouth twice daily **S**
- Risperidone 1 mg oral tablet, one tablet by mouth at bedtime for one week, then stop **S**
- Aripiprazole 10 mg oral tablet, one tablet by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 104/66 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 50.2 kg; BMI 18.4 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.78 mg/dL; eGFR: 105 mL/min/1.73 m²; Lithium (12-hour trough): 0.8 mmol/L; Prolactin: 66 ng/mL (high); PHQ-9: 7. All results are synthetic.

## Change since baseline

- Sodium: 139 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 4 mmol/L at baseline, 4.1 mmol/L at this visit **S**
- Creatinine: 0.72 mg/dL at baseline, 0.78 mg/dL at this visit **S**
- eGFR: 116 mL/min/1.73 m² at baseline, 105 mL/min/1.73 m² at this visit **S**
- Prolactin: 62 ng/mL (high) at baseline, 66 ng/mL (high) at this visit **S**
- PHQ-9: 11 at baseline, 7 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well and well hydrated; weight 50.2 kg; blood pressure 104/66, pulse 74 |
| Neurological | Very faint fine postural tremor; no ataxia; no akathisia or rigidity |
| Psychiatric | Brighter; organized; no psychotic or manic features |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Lithium level above range during dehydration** (T43.595A). Resolved: lithium 0.8 mmol/L five days after restarting, creatinine back to 0.78 mg/dL, sodium 139 and potassium 4.1 mmol/L. The dose suits her; the high level came from dehydration. **S**
   - Continue lithium carbonate 300 mg twice daily.
   - Keep the written sick-day plan on her phone.
2. **Viral gastroenteritis** (A08.4). Resolved. **S**
   - No further action.
3. **Secondary amenorrhea** (N91.1). Prolactin still raised at 66 ng/mL, and no period. Energy intake has improved with the dietitian's plan, so risperidone is now the factor that can be changed. Aripiprazole spares prolactin and has a lower metabolic risk. **S**
   - Switch to aripiprazole 10 mg daily; risperidone 1 mg at bedtime for one week, then stop.
   - Prolactin and periods at the three-month visit.
4. **First episode of psychosis with marked mood symptoms, provisional diagnosis** (F29). No psychotic or manic symptoms; mood improving. Safety reviewed: no thoughts of suicide or self-harm; the safety plan is current. **S**
   - Watch for restlessness or a return of symptoms during the switch and call the team at once.
   - Care coordinator to send reminders for each laboratory test.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Medication safety | Antipsychotic dose, adherence, and response | Every visit | Completed today | Risperidone 2 mg; switching to aripiprazole 10 mg with a one-week taper |
| Survey | Manic, depressive, and psychotic symptoms, and early warning signs | Every visit | Completed today | No manic, depressive-episode, or psychotic symptoms |
| Examination | Akathisia, parkinsonism, and sedation | Every visit in the first months and after any dose change | Completed today | None; to be checked during the switch |
| Examination | Weight and BMI | Every visit for 6 months after starting or changing an antipsychotic (CMID: baseline, 4, 8, and 12 weeks, then quarterly) | Completed today | 50.2 kg, down 0.8 kg after the gastroenteritis |
| Laboratory | Prolactin | When there are symptoms of high prolactin, such as missed periods | Completed today | 66 ng/mL, still raised, with absent periods; antipsychotic switched |
| Laboratory | Lithium level (12-hour trough) | 5 to 7 days after starting and after any change until stable, then every 3 to 6 months | Deferred | The level due 5 to 7 days after starting was not drawn: she felt well and missed the laboratory visit. The first level was at the sick visit (1.4 mmol/L, raised by dehydration, not by the dose). Today 0.8 mmol/L, five days after restarting. Corrective action: the care coordinator sends a reminder before each laboratory test |
| Laboratory | Creatinine and eGFR on lithium | Baseline, every 2 to 3 months for 6 months, then every 6 to 12 months | Completed today | Creatinine 0.78 mg/dL, eGFR 105, back from 1.08 at the sick visit; sodium 139, potassium 4.1 mmol/L |
| Laboratory | TSH on lithium | Baseline, once or twice in the first 6 months, then every 6 to 12 months | Up to date | Baseline normal; next at three months |
| Medication safety | Lithium side effects and sick-day rules | At the start and every visit | Completed today | Faint tremor only; sick-day plan in her phone |
| Medication safety | Pregnancy prevention on lithium; valproate avoided | Before starting and at each visit until a reliable method is in place | Completed today | Condoms used; long-acting methods discussed; she will decide at the preventive visit |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically | Completed today | PHQ-9 7, item 9 scored 0 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current; the 988 Suicide & Crisis Lifeline in her phone |
| Self-management | Sleep | Every visit | Completed today | Eight or nine hours |
| Self-management | Eating, exercise, and periods | Every visit while periods are absent or weight is low | Completed today | Dietitian plan of three meals and two snacks; one gentle class a day; periods absent |
| Self-management | Coordinated specialty care engagement | Ongoing, for up to two to three years | Completed today | Care coordinator weekly; therapist started |

## Goal progress

- No manic, depressive or psychotic episode and no readmission through six months. In progress; target 1930-10-26. **S**
- Lithium trough level 0.6 to 0.8 mmol/L with normal kidney and thyroid tests at six months. In progress; target 1930-10-26. **S**
- Periods return and prolactin is normal by three months. In progress; target 1930-08-10. **S**
- BMI at least 19, with food matched to her training, by six months. In progress; target 1930-10-26. **S**
- PHQ-9 score below 5 by six months. In progress; target 1930-10-26. **S**

## Medication changes

- Stopped: Risperidone 2 mg oral tablet, one tablet by mouth at bedtime (started in hospital) **S**
- Started: Risperidone 1 mg oral tablet, one tablet by mouth at bedtime for one week, then stop **S**
- Started: Aripiprazole 10 mg oral tablet, one tablet by mouth once daily **S**

## Guideline basis

- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018), CANMAT and ISBD (Bipolar Disorders)
- The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence (2023), Focus (American Psychiatric Publishing)
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020), American Psychiatric Association (American Journal of Psychiatry)
- Consensus development conference on antipsychotic drugs and obesity and diabetes (2004), American Diabetes Association, American Psychiatric Association, AACE, and NAASO (Diabetes Care)
- Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026), National Institute of Mental Health
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge

## Follow-up

- Three-month visit in nine weeks, fasting, with lithium level, kidney and thyroid tests, calcium, prolactin, glucose, A1c, and lipids. Care coordinator weekly. **S**
- Next scheduled visit 1930-08-10: three-month review: lithium, thyroid, kidney and metabolic checks, and the diagnosis reviewed. **S**
